Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Truman Knowles
Observed name:
Knowles, Truman
Institution:
University of California, San Francisco
Observed institutions:
Claremont McKenna College,
Scripps College,
University of California, San Francisco,
UCSF Helen Diller Family Comprehensive Cancer Center,
University of San Francisco
ORCID:
0009-0002-9501-823X
Observed ORCID:
0009-0002-9501-823X
OpenAlex ID:
A5101879672
H3K27M mutant glioma: Disease definition and biological underpinnings
2023
·
Amanda M Saratsis
, Truman Knowles
, et al.
·
Neuro-Oncology
·
41
PDF
Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005
2025
·
Bohyeon Yu
, Cassie Kline
, et al.
·
Clinical Cancer Research
·
12
LIN28B and Let-7 in Diffuse Midline Glioma: A Review
2023
·
Truman Knowles
, Tina Huang
, et al.
·
Cancers
·
9
PDF
Prognostic Features of Recurrent Midline and H3 K27M-Mutant Glioma
2025
·
Stephen J. Bagley
, Yoshie Umemura
, et al.
·
Cancers
·
4
PDF
H3K27M Mutant Glioma: Disease Definition and Biological Underpinnings
2024
·
Saratsis, Amanda M; https://orcid.org/0000-0002-4913-2771
, Knowles, Truman
, et al.
·
Zurich Open Repository and Archive (University of Zurich)
·
4
Trls-11. Pnoc005: Oncolytic Measles Virus for the Treatment of Children and Young Adults With Recurrent Medulloblastoma or Atypical Teratoid Rhabdoid Tumor
2024
·
Cassie Kline
, Bohyeon Yu
, et al.
·
Neuro-Oncology
·
3
PDF
Dual treatment with Val-083 and AZD1775 shows potent anti-tumor activity in diffuse midline glioma models
2025
·
Bavani Subramaniam
, Debasish Roy
, et al.
·
npj Precision Oncology
·
2
PDF
Data from Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005
2025
·
Bohyeon Yu
, Cassie Kline
, et al.
·
1
Levetiracetam therapeutically targets GABAergic synapses in diffuse midline glioma
2026
·
Tara Barron
, Richard Drexler
, et al.
·
Nature Medicine
PDF
ID #853 Final report on the treatment modalities and outcomes in pediatric metastatic CNS germinoma: a multi-institutional retrospective analysis
2026
·
Margaret Shatara
, Alexia Thia
, et al.
·
Neuro-Oncology Pediatrics
ID #1008 Trajectory-Based Modeling For Pre-Treatment Prediction of Radiotherapy Response in Diffuse Midline Glioma
2026
·
Daria Laslo
, Thien Phuc Dac Nguyen
, et al.
·
Neuro-Oncology Pediatrics
ID #1110 Evolutionary history of dordaviprone-treated H3K27-altered diffuse midline glioma
2026
·
Bavani Subramaniam
, Francesco Feher
, et al.
·
Neuro-Oncology Pediatrics
ID #764 Building Preclinical Models for Ultra-Rare Pediatric Brain Tumors: Early Outputs of the International Rare Brain Tumor Program (IRBTR)
2026
·
Dipak Poria
, Jessica W Tsai
, et al.
·
Neuro-Oncology Pediatrics
H3K27M-driven hypertranscription leads to a new targetable dependency in diffuse midline gliomas
2026
·
Sharmistha Pal
, Heng Wang
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors
2026
·
Mohammad H. Abu-Arja
, Zeynab Rajabi
, et al.
·
Journal of Neuro-Oncology
EXTH-107. Effective targeting of EGFR-driven diffuse midline glioma with BLU5082, a novel brain-penetrant EGFR-targeting tyrosine kinase inhibitor (TKI)
2025
·
Robert Doherty
, Kelsey Wink
, et al.
·
Neuro-Oncology
PDF
DMG-38. Effective targeting of EGFR-driven diffuse midline glioma with X117195, a novel brain-penetrant EGFR-targeting tyrosine kinase inhibitor (TKI)
2025
·
Robert Doherty
, Kelsey Wink
, et al.
·
Neuro-Oncology Pediatrics
Biom-43. Somatictp53, Pik3r1, Nf1 Ortert Mutations Are Associated With Inferior Clinical Outcome in H3k27m-altered Diffuse Midline Glioma: an International, Multi-institutional Study
2024
·
Thien Nguyen
, Benjamin Lerman
, et al.
·
Neuro-Oncology
PDF
Gct-25. the Impact of Residual Disease on the Outcomes of Central Nervous System Germinomas – a Multicenter Institution Experience
2024
·
Jimin Shin
, Anne Cochrane
, et al.
·
Neuro-Oncology
PDF
Gct-29. Multi-institutional Analysis of Pediatric Relapsed/refractory Central Nervous System Germinomas
2024
·
Mary Claire McGlynn
, Mohammad H Abu-Arja
, et al.
·
Neuro-Oncology
PDF
Gct-21. Multinational Analysis of Pediatric Relapsed/refractory Central Nervous System Non-germinomatous Germ Cell Tumors
2024
·
Mohammad Hatim Abu-Arja
, Mary Claire McGlynn
, et al.
·
Neuro-Oncology
PDF
Gct-05. Updated Report on Treatment Modalities in Metastatic Germinoma in Children: a Multi-institutional Analysis
2024
·
Margaret Shatara
, Alexia Thia
, et al.
·
Neuro-Oncology
PDF
Dipg-77. Somatictp53,pik3r1, Nf1 Ortert Mutations Are Associated With Inferior Clinical Outcome in H3k27m-altered Diffuse Midline Glioma
2024
·
Thien Nguyen
, Benjamin Lerman
, et al.
·
Neuro-Oncology
PDF
Dipg-02. Lin28b Expression in Diffuse Midline Glioma
2024
·
Truman Knowles
, Shejuan An
, et al.
·
Neuro-Oncology
134 LIN28B as a Novel Therapeutic Target in Diffuse Midline Glioma
2024
·
Truman Knowles
, Tina Huang
, et al.
·
Neurosurgery
Show more works
View as search
Works count:
29
Citation count:
76
H-index:
4
I10-index:
2
Year
Topic
Type
